News
A new objective for optimising cancer therapy - The expected lifetime payoff
A new objective for the optimisation of cancer chemotherapy was developed by the Burroughs lab in Tzamarias et al, 2025, https://www.mdpi.com/2227-7390/13/19/3080. They used ideas in branching processes to develop the life-expectancy payoff that averages over outcomes, such as cure and death. It is an interpretable, and in principle parametrisable payoff. Tzamarias, who just submitted his PhD thesis, will continue this work being awarded a 6 month EPSRC postdoctoral pathways fellowship.